Veterinary Portfolio......

Sometime back news was that Merck is planning to disinvest its animal healthcare which it had acquired from Schering- plough corporation deal last year and today Pfizer announced that it is planning to disinvest its animal health assets to Boehringer Ingelheim, these assets it acquired after Wyeth acquisition last year. With this deal Boehringer will be acquiring manufacturing facilities in in US and Canada. The deal includes acquisition of IP related to Wyeth Fort Dodge Animal Health portfolio which includes cattle and small animal vaccines with other some animal health pharmaceuticals. Till now two of the big giants have considered dis investing part of their veterinary product line, what’s next in this segment?